3D‐Printed Biohybrid Microstructures Enable Transplantation and Vascularization of Microtissues in the Anterior Chamber of the Eye
Advanced Materials · 2024
DOI: 10.1002/adma.202306686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Hanie Kavand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Micro- and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, Malvinas Väg 10 pl 5, Stockholm, SE-10044, …. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Islets of Langerhans. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Stiftelsen för Strategisk Forskning, Knut och Alice Wallenbergs Stiftelse.
Abstract (Originalsprache)
Hybridizing biological cells with man‐made sensors enable the detection of a wide range of weak physiological responses with high specificity. The anterior chamber of the eye (ACE) is an ideal transplantation site due to its ocular immune privilege and optical transparency, which enable superior noninvasive longitudinal analyses of cells and microtissues. Engraftment of biohybrid microstructures in the ACE may, however, be affected by the pupillary response and dynamics. Here, sutureless transplantation of biohybrid microstructures, 3D printed in IP‐Visio photoresin, containing a precisely localized pancreatic islet to the ACE of mice is presented. The biohybrid microstructures allow mechanical fixation in the ACE, independent of iris dynamics. After transplantation, islets in the microstructures successfully sustain their functionality for over 20 weeks and become vascularized despite physical separation from the vessel source (iris) and immersion in a low‐viscous liquid (aqueous humor) with continuous circulation and clearance. This approach opens new perspectives in biohybrid microtissue transplantation in the ACE, advancing monitoring of microtissue–host interactions, disease modeling, treatment outcomes, and vascularization in engineered tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Micro- and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, Malvinas Väg 10 pl 5, Stockholm, SE-10044, Sweden.
- Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, Tomtebodavägen 23a, Stockholm, SE-17165, Sweden.
- The Rolf Luft Research center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, SE-17176, Sweden.
- AIMES, Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institutet, Solnavägen 9/B8, Stockholm, SE-17165, Sweden.
ORCID-Profile: Hanie Kavand, Anna Herland
Förderung
- European Research Council
- Stiftelsen för Strategisk Forskning
- Knut och Alice Wallenbergs Stiftelse
- Wenner-Gren Stiftelserna
- Novo Nordisk Fonden
- Familjen Erling-Perssons Stiftelse
- Berth von Kantzows Stiftelse
Zitieren
APA
Kavand, H., Visa, M., Köhler, M., van der Wijngaart, W., Berggren, P. O., & Herland, A. (2024). 3D‐Printed Biohybrid Microstructures Enable Transplantation and Vascularization of Microtissues in the Anterior Chamber of the Eye. Advanced Materials. https://doi.org/10.1002/adma.202306686
Vancouver
Kavand H, Visa M, Köhler M, van der Wijngaart W, Berggren PO, Herland A. 3D‐Printed Biohybrid Microstructures Enable Transplantation and Vascularization of Microtissues in the Anterior Chamber of the Eye. Advanced Materials. 2024. doi:10.1002/adma.202306686
BibTeX
@article{Kavand2024,
author = {Kavand, Hanie and Visa, Montse and Köhler, Martin and van der Wijngaart, Wouter and Berggren, Per-Olof and Herland, Anna},
title = {3D‐Printed Biohybrid Microstructures Enable Transplantation and Vascularization of Microtissues in the Anterior Chamber of the Eye},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202306686}
}
EUVIMED